Market Cap 123.15B
Revenue (ttm) 33.54B
Net Income (ttm) 4.66B
EPS (ttm) N/A
PE Ratio 17.17
Forward PE 17.13
Profit Margin 13.90%
Debt to Equity Ratio 0.60
Volume 6,221,900
Avg Vol 6,783,610
Day's Range N/A - N/A
Shares Out 1.28B
Stochastic %K 19%
Beta 0.71
Analysts Sell
Price Target $111.04

Company Profile

Medtronic plc develops, manufactures, and sells device-based medical therapies to healthcare systems, physicians, clinicians, and patients in the United States, Ireland, and internationally. The Cardiovascular Portfolio segment offers implantable cardiac pacemakers, cardioverter defibrillators, and cardiac resynchronization therapy devices; cardiac ablation products; insertable cardiac monitor systems; TYRX products; and remote monitoring and patient-centered software. It also provides aortic va...

Industry: Medical Devices
Sector: Healthcare
Phone: 353 1 438 1700
Address:
Building Two, Parkmore Business Park West, Galway, Ireland
Game_Day
Game_Day Jan. 2 at 2:17 AM
Jan 2 $MDT potential 97.50+ tests $TSLA potential 460+ tests
0 · Reply
BuddyBoy6975
BuddyBoy6975 Jan. 1 at 3:08 PM
0 · Reply
EliteStockTrader
EliteStockTrader Jan. 1 at 1:02 PM
$MDT Current Price & Change: $96.06 (-0.62%) Trend Indicator: Bullish RSI Level: 19.8 Volume Activity: -17.4% vs avg Volatility: 0.68% Price Target: $95.99 Confidence: 81% I do not provide personalized financial advice or sell premium subscriptions. Any communication requesting payment for services is unauthorized. My only official outlet is https://stocksecret.news Always conduct your own due diligence.
0 · Reply
N0Bounds
N0Bounds Dec. 31 at 10:34 PM
SNSE is the Next big Retail Squeeze!! $MDT $ALT $SHEL $DAVE $VALE 3
0 · Reply
RinaGuerrera510
RinaGuerrera510 Dec. 31 at 5:26 PM
$HON $SMFG $MDT $CB $BTI Strong analysis
0 · Reply
Rumplenickledime
Rumplenickledime Dec. 30 at 11:22 AM
$MDT should make a deal with $BEAT
0 · Reply
PolycarpFX
PolycarpFX Dec. 30 at 2:47 AM
$MDT gap filled
0 · Reply
topstockalerts
topstockalerts Dec. 29 at 4:27 PM
After two years of underperformance, healthcare stocks broadly matched the market in 2025 as investors rotated out of technology. The outlook for 2026 remains mixed, with fundamentals still pressured by patent expirations, Medicare Advantage challenges, and political risks, but several key themes could drive performance. Alzheimer’s research is regaining attention, led by Eli Lilly’s Trailblazer-ALZ-3 trial testing whether early intervention can delay disease onset. A positive outcome could reshape treatment strategies and significantly expand the market. UnitedHealth Group is also in focus after its shares collapsed in spring 2025 due to Medicare Advantage problems; management is targeting a return to double-digit growth starting in 2027, though execution will be closely watched. Another major theme is the launch of oral GLP-1 weight-loss drugs from Lilly and Novo Nordisk. $LLY $BIIB $UNH $MDT $SPX
0 · Reply
SPYmyQQQ
SPYmyQQQ Dec. 29 at 1:02 PM
🚀 New Signal ✅ 🏛️ $MDT 🗓️ Dec 29, 2025 💵 Entry: $96.40 🎯 Target (Opt.): $98.74 (+2.43%) 👉 FREE TRIAL! spymyqqq/join/
0 · Reply
BinaryLogic
BinaryLogic Dec. 27 at 6:02 PM
0 · Reply
Latest News on MDT
Best Dividend Aristocrats For January 2026

Dec 31, 2025, 8:47 AM EST - 2 days ago

Best Dividend Aristocrats For January 2026

ABBV ABT ADM ADP AFL ALB AMCR


MiniMed Group Files For IPO In Medtronic Carve-Out

Dec 22, 2025, 12:21 PM EST - 11 days ago

MiniMed Group Files For IPO In Medtronic Carve-Out

MMED


Medtronic: A Defensive Gem For Uncertain Times

Dec 20, 2025, 1:07 AM EST - 14 days ago

Medtronic: A Defensive Gem For Uncertain Times


Medtronic Spin-Off MiniMed Files for IPO

Dec 19, 2025, 4:53 PM EST - 14 days ago

Medtronic Spin-Off MiniMed Files for IPO

MMED


Medtronic's MiniMed files for US IPO

Dec 19, 2025, 4:16 PM EST - 14 days ago

Medtronic's MiniMed files for US IPO

MMED


Dividend Income: Lanny's October 2025 Summary

Dec 15, 2025, 3:29 AM EST - 19 days ago

Dividend Income: Lanny's October 2025 Summary

BNL BNS BRT CAH CM CSCO DEO


Medtronic: This Dividend Aristocrat Is Just Getting Started

Dec 9, 2025, 10:41 AM EST - 24 days ago

Medtronic: This Dividend Aristocrat Is Just Getting Started


Best Dividend Aristocrats For December 2025

Nov 29, 2025, 8:02 AM EST - 4 weeks ago

Best Dividend Aristocrats For December 2025

ABBV ABT ADM ADP AFL ALB AMCR


Medtronic plc (MDT) Q2 2026 Earnings Call Transcript

Nov 18, 2025, 12:08 PM EST - 6 weeks ago

Medtronic plc (MDT) Q2 2026 Earnings Call Transcript


Medtronic Lifts Outlook as Quarterly Profit, Sales Rise

Nov 18, 2025, 7:44 AM EST - 6 weeks ago

Medtronic Lifts Outlook as Quarterly Profit, Sales Rise


Medtronic: Possible Earnings Beat Incoming But Still Overvalued

Nov 11, 2025, 4:04 PM EST - 7 weeks ago

Medtronic: Possible Earnings Beat Incoming But Still Overvalued


Best Dividend Aristocrats For November 2025

Nov 1, 2025, 10:25 AM EDT - 2 months ago

Best Dividend Aristocrats For November 2025

ABBV ABT ADM ADP AMCR AOS ATO


Medtronic: A Revitalized Dividend Aristocrat To Buy Now

Oct 26, 2025, 12:12 PM EDT - 2 months ago

Medtronic: A Revitalized Dividend Aristocrat To Buy Now


Medtronic Stock's $50 Billion Gift To Investors

Oct 13, 2025, 6:45 AM EDT - 2 months ago

Medtronic Stock's $50 Billion Gift To Investors


Medtronic plc - Special Call

Oct 9, 2025, 2:56 PM EDT - 3 months ago

Medtronic plc - Special Call


Medtronic: FY26 Outlook Strengthened By New Product Launches

Sep 25, 2025, 8:13 AM EDT - 3 months ago

Medtronic: FY26 Outlook Strengthened By New Product Launches


Medtronic: Buy This Dividend Aristocrat While It's Good Value

Sep 17, 2025, 11:59 AM EDT - 3 months ago

Medtronic: Buy This Dividend Aristocrat While It's Good Value


Medtronic Announces Pricing of €1.5 Billion of Senior Notes

Sep 15, 2025, 5:41 PM EDT - 3 months ago

Medtronic Announces Pricing of €1.5 Billion of Senior Notes


Game_Day
Game_Day Jan. 2 at 2:17 AM
Jan 2 $MDT potential 97.50+ tests $TSLA potential 460+ tests
0 · Reply
BuddyBoy6975
BuddyBoy6975 Jan. 1 at 3:08 PM
0 · Reply
EliteStockTrader
EliteStockTrader Jan. 1 at 1:02 PM
$MDT Current Price & Change: $96.06 (-0.62%) Trend Indicator: Bullish RSI Level: 19.8 Volume Activity: -17.4% vs avg Volatility: 0.68% Price Target: $95.99 Confidence: 81% I do not provide personalized financial advice or sell premium subscriptions. Any communication requesting payment for services is unauthorized. My only official outlet is https://stocksecret.news Always conduct your own due diligence.
0 · Reply
N0Bounds
N0Bounds Dec. 31 at 10:34 PM
SNSE is the Next big Retail Squeeze!! $MDT $ALT $SHEL $DAVE $VALE 3
0 · Reply
RinaGuerrera510
RinaGuerrera510 Dec. 31 at 5:26 PM
$HON $SMFG $MDT $CB $BTI Strong analysis
0 · Reply
Rumplenickledime
Rumplenickledime Dec. 30 at 11:22 AM
$MDT should make a deal with $BEAT
0 · Reply
PolycarpFX
PolycarpFX Dec. 30 at 2:47 AM
$MDT gap filled
0 · Reply
topstockalerts
topstockalerts Dec. 29 at 4:27 PM
After two years of underperformance, healthcare stocks broadly matched the market in 2025 as investors rotated out of technology. The outlook for 2026 remains mixed, with fundamentals still pressured by patent expirations, Medicare Advantage challenges, and political risks, but several key themes could drive performance. Alzheimer’s research is regaining attention, led by Eli Lilly’s Trailblazer-ALZ-3 trial testing whether early intervention can delay disease onset. A positive outcome could reshape treatment strategies and significantly expand the market. UnitedHealth Group is also in focus after its shares collapsed in spring 2025 due to Medicare Advantage problems; management is targeting a return to double-digit growth starting in 2027, though execution will be closely watched. Another major theme is the launch of oral GLP-1 weight-loss drugs from Lilly and Novo Nordisk. $LLY $BIIB $UNH $MDT $SPX
0 · Reply
SPYmyQQQ
SPYmyQQQ Dec. 29 at 1:02 PM
🚀 New Signal ✅ 🏛️ $MDT 🗓️ Dec 29, 2025 💵 Entry: $96.40 🎯 Target (Opt.): $98.74 (+2.43%) 👉 FREE TRIAL! spymyqqq/join/
0 · Reply
BinaryLogic
BinaryLogic Dec. 27 at 6:02 PM
0 · Reply
Ro_Patel
Ro_Patel Dec. 24 at 11:49 PM
CBOE: Today's option volume of 32.6M contracts was -47.00% below recent avg levels, w/ calls leading puts 5 to 4. Today's most active sectors included Telecommunications, Consumer Non-Cyclicals, & Basic Materials, while Financials & Utilities were relatively light. Among the 500 most liquid single stocks, 30day IV was higher for 219 & lower for 231. Unusual total option volume was observed in $NKE $PM $ASTS $CDE & $MDT
0 · Reply
Neahrain8
Neahrain8 Dec. 24 at 4:58 PM
0 · Reply
WholeUnitW
WholeUnitW Dec. 24 at 3:59 PM
$MDT Future valuation dynamics revolve around proof that pricing power can persist through normalization phases, with outcomes shaped by timing and discipline. Operational proof points remain decisive.
0 · Reply
ZacksResearch
ZacksResearch Dec. 22 at 5:45 PM
Winning streaks into 2026? Big MedTech says yes. 🏥📈 Four large-cap MedTech leaders — $MDT, $ISRG, $CAH, and $EW — appear well-positioned to keep momentum going into 2026, backed by resilient procedure demand and ongoing innovation driving their businesses. Want the full breakdown on what’s powering these names? See the full MedTech outlook here 👉 https://www.zacks.com/stock/news/2807489/4-large-cap-medtech-stocks-to-keep-winning-streaks-alive-in-2026?cid=sm-stocktwits-2-2807489-teaser-25846&ADID=SYND_STOCKTWITS_TWEET_2_2807489_TEASER_25846
0 · Reply
DefenseMania
DefenseMania Dec. 20 at 2:47 AM
$MDT interesting Medtronic bought out MiniMed about 25 years ago at the time it was a publicly traded company MNMD And now they’re going to spin it off again lol Curious to see what the shareholders will get . $GILD $ABBV $ISRG
1 · Reply
AStrokeOfLuck
AStrokeOfLuck Dec. 20 at 1:05 AM
0 · Reply
RoyalPurp
RoyalPurp Dec. 19 at 11:09 AM
$ANVS $MDT A great study to be conducted. Patients using DBS (deep brain stimulation, coupled with buntanetap could be a great match. 💪 https://www.annovisbio.com/press-release/annovis-announces-open-label-extension-study-for-parkinsons-disease-patients
0 · Reply
JarvisFlow
JarvisFlow Dec. 18 at 3:49 PM
Truist Securities has updated their rating for Medtronic ( $MDT ) to Hold with a price target of 107.
0 · Reply
QuantitativeTrading_
QuantitativeTrading_ Dec. 18 at 12:59 PM
Brain-computer interface boom starting, most watch Neuralink — supply chain richer. Gold rush: shovel sellers. BCI "picks and shovels": $MDT: Medical devices $ABT: Neuro tech $SEM: Electrode materials $NVCR: Brain therapy $ISRG: Precision tools
0 · Reply
KenFaulkenberry
KenFaulkenberry Dec. 17 at 3:20 PM
Medtronic (MDT) Stock Analysis (Dividend Aristocrat) The company offers exposure to long-term healthcare trends such as aging populations and chronic disease management, making it a potentially stable and defensive investment.. For investors seeking dependable income and exposure to medical innovation, $MDT could be a worthwhile holding. Is the stock price a Buy, Sell, or Hold? What is the Intrinsic Value of Medtronic (MDT)? https://dividendvaluebuilder.com/medtronic-mdt-dividend-stock-analysis/
0 · Reply
StockAnalyst_SA
StockAnalyst_SA Dec. 17 at 2:45 AM
A List of Robotics Stocks: Healthcare Robotics $ISRG Intuitive Surgical $SYK Stryker $MDT Medtronic $ARAY Accuray $PRCT PROCEPT
0 · Reply
BrightStars
BrightStars Dec. 16 at 9:18 PM
$BEAT so I was looking at who would be interested in buying this product and use it with their already aligned products. One company came to mind. $MDT What would be the chances of the interested party being MDT? Hmmmm If anyone knows anything…let us all know.
0 · Reply